[关键词]
[摘要]
免疫监视是防止肝细胞癌(HCC)进展与复发的关键生物学机制。然而,HCC易逃避免疫监视,且对免疫检查点阻断疗法普遍耐受;免疫检查点阻断疗法的客观应答率始终维持在15%~20%的低水平。近年来,越来越多的研究表明,HCC相关的胆固醇代谢重编程是驱动免疫逃逸和免疫检查点阻断疗法治疗抵抗的核心机制之一。这一代谢重塑不仅满足肿瘤生长对膜结构和信号转导的需求,还通过产生具有免疫调节活性的代谢物,构建多层级免疫抑制网络,系统性削弱肝免疫监视功能,促进肿瘤进展、免疫逃逸和复发。本文系统梳理了肝免疫监视在HCC发生发展中的作用,重点综述胆固醇的生物合成、转化与氧化代谢通路及其在免疫抑制中的功能,并总结靶向胆固醇代谢以增强免疫治疗疗效的最新进展。本文通过整合代谢、分子信号和肿瘤免疫学研究,为全面理解HCC免疫逃逸机制及开发基于代谢干预的治疗策略提供理论依据。
[Key word]
[Abstract]
Immune surveillance is a critical biological mechanism preventing the progression and recurrence of hepatocellular carcinoma (HCC). However, HCC readily evades immune surveillance and exhibits widespread resistance to immune checkpoint blockade (ICB) therapy, with objective response rates remaining low at 15%-20%. In recent years, growing evidence has shown that HCC-associated cholesterol metabolic reprogramming is a central mechanism driving immune evasion and ICB resistance. This metabolic remodeling not only fulfills the membrane structure and signal transduction demands required for tumor growth, but also generates immunomodulatory metabolites that build a multi-layered immunosuppressive network. Consequently, it systematically impairs hepatic immune surveillance, promoting tumor progression, immune evasion, and recurrence. Here, we systematically review the role of hepatic immune surveillance in HCC initiation and development, focusing on the biosynthesis, transformation, and oxidative pathways of cholesterol, as well as their immunosuppressive functions. Furthermore, we summarize recent advances in targeting cholesterol metabolism to enhance the efficacy of immunotherapy. By integrating findings from metabolism, molecular signaling, and tumor immunology, this review provides a theoretical foundation for comprehensively understanding HCC immune evasion mechanisms and developing therapeutic strategies based on metabolic interventions.
[中图分类号]
[基金项目]
国家重点研发计划(2023YFC2505900)